AST 2013 - Cutting Edge of Transplantation


TH03 - Trying to Treat the Known Unknown


Feb 14, 2013 5:40pm ‐ Feb 14, 2013 6:00pm

Description

Much remains to be learned regarding anti-HLA antibodies in transplantation. A few of the examples where additional knowledge is needed include: 1) Factors that influence the marked variations in clinical phenotypes exhibited by antibody-mediated processes, 2) Processes that determine whether cellular or humoral mechanisms (or both) predominate in the alloresponse to human allografts, 3) Factors that influence antibody production, and responses to antihumoral therapies, 4) the extent to which antibody elimination is needed to achieve optimal results with antihumoral therapies.

What You'll Take Away from His Talk:

  • Accumulation of knowledge regarding anti HLA alloantibodies in transplantation is proceeding at a fast pace.
  • Requisite basic science in mice and humans is substantial but a broader and deeper understanding is needed.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content